Kanada - angličtina - Health Canada

accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 30mg - oseltamivir (oseltamivir phosphate) 30mg

Kanada - angličtina - Health Canada

accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 45mg - oseltamivir (oseltamivir phosphate) 45mg

Kanada - angličtina - Health Canada

accord healthcare inc - oseltamivir (oseltamivir phosphate) - capsule - 75mg - oseltamivir (oseltamivir phosphate) 75mg

Európska únia - angličtina - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influenza, human - influenza vaccines, influenza, live attenuated - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. the use of fluenz tetra should be based on official recommendations.

Európska únia - angličtina - EMA (European Medicines Agency)

astrazeneca ab - reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.pandemic influenza vaccine h5n1 astrazeneca should be used in accordance with official guidance

Kanada - angličtina - Health Canada

biocryst pharmaceuticals inc - peramivir - solution - 10mg - peramivir 10mg - neuraminidase inhibitors

Spojené štáty - angličtina - NLM (National Library of Medicine)

dispensing solutions, inc. - oseltamivir phosphate (unii: 4a3o49ngez) (oseltamivir - unii:20o93l6f9h) - oseltamivir 12 mg in 1 ml

Spojené štáty - angličtina - NLM (National Library of Medicine)

rebel distributors corp - oseltamivir phosphate (unii: 4a3o49ngez) (oseltamivir - unii:20o93l6f9h) - oseltamivir 75 mg

Spojené štáty - angličtina - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - oseltamivir phosphate (unii: 4a3o49ngez) (oseltamivir carboxylate - unii:k6106lv5q8) - oseltamivir carboxylate 75 mg - oseltamivir phosphate capsules, usp is indicated for the treatment of acute, uncomplicated illness due to influenza a and b infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. oseltamivir phosphate is indicated for the prophylaxis of influenza a and b in patients 1 year and older. - oseltamivir phosphate capsules is not a substitute for early influenza vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices. - influenza viruses change over time. emergence of resistance substitutions could decrease drug effectiveness. other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate capsules [see microbiology (12.4)]. -  oseltamivir phosphate capsules is not recommended f

Spojené štáty - angličtina - NLM (National Library of Medicine)

remedyrepack inc. - oseltamivir phosphate (unii: 4a3o49ngez) (oseltamivir acid - unii:k6106lv5q8) - oseltamivir acid 75 mg